Merck and Kelun's lung cancer combo bests Keytruda in late-stage trial
Merck & Co., Inc. · PHARMACEUTICAL PREPARATIONS · Now $115.17
-2.1% in 3d after detection
Post-detection moves
1h
+1.4%
1d
+0.4%
3d
-2.1%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS